Institut Bergonié

This study tests whether freezing a tumor (cryoablation) alongside standard immunotherapy and chemotherapy helps people with advanced lung cancer live longer. About 214 adults with metastatic lung adenocarcinoma will be randomly assigned to receive either the standard drug combo …

This study tests whether combining two drugs, pembrolizumab and cabozantinib, can stop or shrink advanced sarcomas (soft tissue and bone cancers). About 119 adults whose cancer has worsened after standard treatment will take part. The main goal is to see how many patients have no…

This study is building a huge database of medical and biological information from up to 150,000 people with sarcoma in France. Researchers will use this data to learn how patients are treated and what affects their outcomes. No new treatments are being tested; the goal is to gath…

This study aims to find genetic changes in the tumors of 10,000 people with advanced cancer. By analyzing their DNA and immune system, researchers hope to match each person to a targeted drug or clinical trial that might work best for them. The goal is to make cancer treatment mo…

This study looks at proteins called convertases in pancreatic tumor samples from 50 patients. Researchers want to see if the levels of these proteins are linked to the immune cells around the tumor, which might help predict how the disease will progress. The goal is to find new w…

This study is for people with invasive breast cancer who had chemotherapy before surgery, but whose tumors did not completely disappear. Researchers will take blood samples over time to look for tiny pieces of tumor DNA (ctDNA). The goal is to see if these DNA clues can predict w…

This study looks at a radioactive drug (177Lu-PSMA-617) used for advanced prostate cancer that has spread. Researchers want to measure how much radiation the tumor and healthy organs receive, and see if higher doses lead to better response or more side effects. About 50 adults wi…